Ocumetics Technology Corp. (TSXV:OTC)

Ocumetics Technology Income Statement

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Jul 31, 2021
Selling, General & Admin	1.17	1.21	2.05	1	1.1	0.56
Research & Development	0.89	0.85	0.91	0.56	0.24	-
Operating Expenses	2.33	2.37	3.56	2.14	2.01	0.65
Operating Income	-2.33	-2.37	-3.56	-2.14	-2.01	-0.65
Interest Expense	-0.64	-0.64	-0.03	-0.03	-0.03	-
Interest & Investment Income	0.04	0.04	-	-	-	-
Currency Exchange Gain (Loss)	-0.05	-0.04	-0.01	-0.01	-0	-
Other Non Operating Income (Expenses)	-0.33	-0.06	-0.04	-	-0.14	-
EBT Excluding Unusual Items	-3.31	-3.06	-3.64	-2.18	-2.17	-0.65
Other Unusual Items	-	-	-	-0.04	-1.37	-
Pretax Income	-3.31	-3.06	-3.64	-2.22	-3.54	-0.65
Income Tax Expense	-0.04	-0.04	-	-	-	-
Net Income	-3.27	-3.02	-3.64	-2.22	-3.54	-0.65
Net Income to Common	-3.27	-3.02	-3.64	-2.22	-3.54	-0.65
Shares Outstanding (Basic)	120	120	115	110	104	68
Shares Outstanding (Diluted)	120	120	115	110	104	68
Shares Change (YoY)	2.20%	3.77%	5.15%	5.93%	52.00%	206.74%
EPS (Basic)	-0.03	-0.03	-0.03	-0.02	-0.03	-0.01
EPS (Diluted)	-0.03	-0.03	-0.03	-0.02	-0.03	-0.01
Free Cash Flow	-2.57	-2.43	-2.12	-1.62	-2.45	-0.09
Free Cash Flow Per Share	-0.02	-0.02	-0.02	-0.01	-0.02	-0.00
EBITDA	-2.2	-2.23	-3.45	-2.04	-1.91	-0.56
D&A For EBITDA	0.14	0.13	0.12	0.1	0.1	0.08
EBIT	-2.33	-2.37	-3.56	-2.14	-2.01	-0.65

Updated Nov 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.